Skip to content

Clinical trials

Phase 3 Epilepsy trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 3 Country / region: Austria Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20073
20081
20102
20111
20132
20141
20171
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma3
Xenon Pharmaceuticals Inc.3
Bial - Portela C S.A.2
UCB BIOSCIENCES, Inc.2
Eisai Inc.1
Janssen Research & Development, LLC1
Novartis Pharmaceuticals1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
UCB Biopharma S.P.R.L.1
UCB Pharma SA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy16
Seizures3
Epilepsies, Partial1
Headache1
Migraine Disorders1
Recurrence1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.